Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Funding
Biotech

Enveda reaps $311M round to help become ‘household name’

The series E round positions the nature-derived drug discovery company to pursue its goal of becoming a household name over the next decade.
Nick Paul Taylor Sep 23, 2026 9:47am
Flagship Pioneering office

Trump's Department of War bets $47M for emerging threat research

Sep 23, 2026 9:35am
als

Beyond clinical endpoints: Rethinking ALS drug development through disease biology

Brought to you by Neurizon Therapeutics
Make a delay and accumulation of outstanding tasks Full stop

Immunovant ends cutaneous lupus program after phase 2 flop

Sep 23, 2026 8:59am
video
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
Boehringer Ingelheim

Boehringer adds $250M to Variant pact via cardio expansion

Sep 23, 2026 8:55am